EPI vs NOX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EPI

EPIMINDER FPO [EPI]

50MEDIUM

NOX

NOXOPHARM FPO [NOX]

50MEDIUM

Score Breakdown

EPI NOX
Technical
59
54
Catalyst
55
50
Sentiment
50
50
Fundamental
78
29
Momentum
35
60
Risk Gate
42
43

Key Metrics

EPI Metric NOX
$110.4MMarket Cap$19.7M
90KAvg Volume (20d)81K
N/AShort InterestN/A
$1.49052-Week High$0.135
$0.62052-Week Low$0.043
+0.0%Daily Change+6.7%
$0.630Entry Price$0.064
N/AROE-343.6%
N/AProfit Margin-161.7%

Active Signals

EPI Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Volume surging at 3.1x normal while price falls — heavy selling pressure
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Drifting lower — down 3.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Adequate cash runway (8 quarters)

NOX Signals

MACD momentum is picking up steam
Volume surging at 4.1x normal while price falls — heavy selling pressure
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.1 quarters)
Moderate P/S ratio (5.8x)
Strong revenue growth (+50%)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare EPI and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EPI Full Analysis → NOX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).